gno.law

H.(T.) v. Novartis Pharm. Corp.

California Supreme Court · No. S233898. · 2016-06-08 · Published · 203 Cal. Rptr. 3d 22 · 371 P.3d 241

H. (T.) v. NOVARTIS PHARMACEUTICALS CORPORATION.

Area
civil
Panel
Cantil (author), Carol A. Corrigan, Goodwin H. Liu, Chin, Sakauye, Mariano-Florentino Cuéllar, Leondra R. Kruger

Analysis

No analysis yet. When one exists it is a model's reading of this opinion — the rulings it reviewed, whether it agrees with the court, and the authorities it checked — shown beside the court's own disposition, never in place of it. How analyses are made.

Opinion

The applications to appear as counsel pro hac vice are granted. The petition for review is granted. The issue to be briefed and argued is limited to the following: May the brand name manufacturer of a pharmaceutical drug that divested all ownership interest in the drug be held liable for injuries caused years later by another manufacturer's generic version of that drug?

WERDEGAR, J., was recused and did not participate.